Endoscopic transpapillary gallbladder drainage: 10-Year single center experience

Rahul Pannala, Bret Thomas Petersen, C. J. Gostout, Mark Topazian, M. J. Levy, T. H. Baron

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Aim. A subset of patients with acute cholecystitis is severely ill and extremely high-risk to undergo cholecystectomy. Data on the use of endoscopic transpapillary gallbladder drainage (ETGBD) in the treatment of acute cholecystitis are limited. This article reviews the 10-year experience of ETGBD at Mayo Clinic and evaluated patient and procedure characteristics. Methods. A retrospective review of the endoscopy database from 1998-2007 was performed to identify patients who had undergone ETGBD. Clinical information and procedure details were abstracted from the electronic medical record. Results. Fifty one patients underwent ETGBD for acute cholecystitis between 1998 to July 2007. The mean age was 62±19 years and 67% of patients were males. The median number of comorbid medical conditions was two (range 0-5) and 27% had underlying diabetes mellitus. Acute calculous cholecystitis was the predominant indication for ETGBD (78%). A gallbladder stent was used in 33 (65%) patients, nasocholecystic drain in 14 (27%) patients, and both in four patients (8%). Bleeding (4%) and sedation-related complications (4%) were the most common complications noted. Among patients who underwent cholecystectomy, the majority (76%) needed an open procedure. The median time to cholecystectomy was 15 days (range 1-352 days). Four patients (8%) succumbed to septic shock during their hospitalization. Conclusion. ETGBD is a valuable alternative therapeutic modality for the treatment of patients with acute cholecystitis who are at high-risk for early cholecystectomy, and/or those who have contraindications to percutaneous gallbladder drainage.

Original languageEnglish (US)
Pages (from-to)107-113
Number of pages7
JournalMinerva Gastroenterologica e Dietologica
Volume54
Issue number2
StatePublished - Jun 2008

Fingerprint

Gallbladder
Drainage
Acute Cholecystitis
Cholecystectomy
Electronic Health Records
Septic Shock
Endoscopy
Stents
Diabetes Mellitus
Hospitalization
Therapeutics
Databases
Hemorrhage

Keywords

  • Cholangio-pancreatography, endoscopic retrograde
  • Cholecystitis, acute
  • Gallbladder

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Endoscopic transpapillary gallbladder drainage : 10-Year single center experience. / Pannala, Rahul; Petersen, Bret Thomas; Gostout, C. J.; Topazian, Mark; Levy, M. J.; Baron, T. H.

In: Minerva Gastroenterologica e Dietologica, Vol. 54, No. 2, 06.2008, p. 107-113.

Research output: Contribution to journalArticle

@article{b205a9884dfb44b788961e7cdfa9634d,
title = "Endoscopic transpapillary gallbladder drainage: 10-Year single center experience",
abstract = "Aim. A subset of patients with acute cholecystitis is severely ill and extremely high-risk to undergo cholecystectomy. Data on the use of endoscopic transpapillary gallbladder drainage (ETGBD) in the treatment of acute cholecystitis are limited. This article reviews the 10-year experience of ETGBD at Mayo Clinic and evaluated patient and procedure characteristics. Methods. A retrospective review of the endoscopy database from 1998-2007 was performed to identify patients who had undergone ETGBD. Clinical information and procedure details were abstracted from the electronic medical record. Results. Fifty one patients underwent ETGBD for acute cholecystitis between 1998 to July 2007. The mean age was 62±19 years and 67{\%} of patients were males. The median number of comorbid medical conditions was two (range 0-5) and 27{\%} had underlying diabetes mellitus. Acute calculous cholecystitis was the predominant indication for ETGBD (78{\%}). A gallbladder stent was used in 33 (65{\%}) patients, nasocholecystic drain in 14 (27{\%}) patients, and both in four patients (8{\%}). Bleeding (4{\%}) and sedation-related complications (4{\%}) were the most common complications noted. Among patients who underwent cholecystectomy, the majority (76{\%}) needed an open procedure. The median time to cholecystectomy was 15 days (range 1-352 days). Four patients (8{\%}) succumbed to septic shock during their hospitalization. Conclusion. ETGBD is a valuable alternative therapeutic modality for the treatment of patients with acute cholecystitis who are at high-risk for early cholecystectomy, and/or those who have contraindications to percutaneous gallbladder drainage.",
keywords = "Cholangio-pancreatography, endoscopic retrograde, Cholecystitis, acute, Gallbladder",
author = "Rahul Pannala and Petersen, {Bret Thomas} and Gostout, {C. J.} and Mark Topazian and Levy, {M. J.} and Baron, {T. H.}",
year = "2008",
month = "6",
language = "English (US)",
volume = "54",
pages = "107--113",
journal = "Minerva Gastroenterologica",
issn = "0026-4776",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "2",

}

TY - JOUR

T1 - Endoscopic transpapillary gallbladder drainage

T2 - 10-Year single center experience

AU - Pannala, Rahul

AU - Petersen, Bret Thomas

AU - Gostout, C. J.

AU - Topazian, Mark

AU - Levy, M. J.

AU - Baron, T. H.

PY - 2008/6

Y1 - 2008/6

N2 - Aim. A subset of patients with acute cholecystitis is severely ill and extremely high-risk to undergo cholecystectomy. Data on the use of endoscopic transpapillary gallbladder drainage (ETGBD) in the treatment of acute cholecystitis are limited. This article reviews the 10-year experience of ETGBD at Mayo Clinic and evaluated patient and procedure characteristics. Methods. A retrospective review of the endoscopy database from 1998-2007 was performed to identify patients who had undergone ETGBD. Clinical information and procedure details were abstracted from the electronic medical record. Results. Fifty one patients underwent ETGBD for acute cholecystitis between 1998 to July 2007. The mean age was 62±19 years and 67% of patients were males. The median number of comorbid medical conditions was two (range 0-5) and 27% had underlying diabetes mellitus. Acute calculous cholecystitis was the predominant indication for ETGBD (78%). A gallbladder stent was used in 33 (65%) patients, nasocholecystic drain in 14 (27%) patients, and both in four patients (8%). Bleeding (4%) and sedation-related complications (4%) were the most common complications noted. Among patients who underwent cholecystectomy, the majority (76%) needed an open procedure. The median time to cholecystectomy was 15 days (range 1-352 days). Four patients (8%) succumbed to septic shock during their hospitalization. Conclusion. ETGBD is a valuable alternative therapeutic modality for the treatment of patients with acute cholecystitis who are at high-risk for early cholecystectomy, and/or those who have contraindications to percutaneous gallbladder drainage.

AB - Aim. A subset of patients with acute cholecystitis is severely ill and extremely high-risk to undergo cholecystectomy. Data on the use of endoscopic transpapillary gallbladder drainage (ETGBD) in the treatment of acute cholecystitis are limited. This article reviews the 10-year experience of ETGBD at Mayo Clinic and evaluated patient and procedure characteristics. Methods. A retrospective review of the endoscopy database from 1998-2007 was performed to identify patients who had undergone ETGBD. Clinical information and procedure details were abstracted from the electronic medical record. Results. Fifty one patients underwent ETGBD for acute cholecystitis between 1998 to July 2007. The mean age was 62±19 years and 67% of patients were males. The median number of comorbid medical conditions was two (range 0-5) and 27% had underlying diabetes mellitus. Acute calculous cholecystitis was the predominant indication for ETGBD (78%). A gallbladder stent was used in 33 (65%) patients, nasocholecystic drain in 14 (27%) patients, and both in four patients (8%). Bleeding (4%) and sedation-related complications (4%) were the most common complications noted. Among patients who underwent cholecystectomy, the majority (76%) needed an open procedure. The median time to cholecystectomy was 15 days (range 1-352 days). Four patients (8%) succumbed to septic shock during their hospitalization. Conclusion. ETGBD is a valuable alternative therapeutic modality for the treatment of patients with acute cholecystitis who are at high-risk for early cholecystectomy, and/or those who have contraindications to percutaneous gallbladder drainage.

KW - Cholangio-pancreatography, endoscopic retrograde

KW - Cholecystitis, acute

KW - Gallbladder

UR - http://www.scopus.com/inward/record.url?scp=44349144054&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44349144054&partnerID=8YFLogxK

M3 - Article

C2 - 18319682

AN - SCOPUS:44349144054

VL - 54

SP - 107

EP - 113

JO - Minerva Gastroenterologica

JF - Minerva Gastroenterologica

SN - 0026-4776

IS - 2

ER -